HIV-induced immune activation is a hallmark of HIV pathogenesis and disease progression. This includes hyperactivation of B cells with increased differentiation of B cells to plasmablasts (PB) and a decrease in memory B cells (BMem). We evaluated the effects of antiretroviral therapy (ART) initiated during acute HIV infection (AHI) on mucosal B cells.
Individuals at Fiebig stages I to III of AHI, underwent sigmoid biopsy at the time of HIV diagnosis (AHI; n=14) and 24 months post ART initiation (n=18). Matched HIV-uninfected (HIV-; n=33) and individuals who had initiated ART during chronic HIV infection (CHI – 12 to 36 months post ART initiation; n=6) served as controls. Mucosal mononuclear cells were isolated and multiparameter flow cytometry was performed to determine the frequency of B cell subsets (PB: Lin-CD20+/-CD19+CD27hiCD38hi; BMem: Lin-CD20+CD19+CD27+CD38-IgD-IgM-).
Median gut HIV RNA was 3.8 log10 [copies/mg tissue] at AHI diagnosis and undetectable after 24 months of ART in 17/18 participants (p≤0.001). There was no difference observed in the frequency of PB and BMem between the time of AHI diagnosis and HIV- individuals (PB: 6.3% vs 8.2%, BMem: 58.0% vs 53.7%, respectively). However, 24 months post ART initiation a significant increase in the frequency of PB to 17.1% was observed compared to time of AHI diagnosis (6.3%, p≤0.01) and compared to HIV- (8.2%, p≤0.0001), which was similar to the frequency of PB in CHI (14.8%, p=0.24). The frequency of BMem decreased from 58.0% during AHI diagnosis to 50.1% at 24 months post ART initiation (p≤0.01). Following 24 months of ART the frequency of BMem (50.1%) was lower compared to HIV- (53.7%, p=0.03), but remained significantly higher compared to CHI (35.0%, p≤0.05). Interestingly, the expression of IgA, the most abundant isotype produced by mucosal PB, was higher in CHI compared to AHI following 24 months of ART (10.8% vs 4.7%, p=0.03), with no increase observed between AHI diagnosis and 24 months post ART initiation (6.1% vs 4.7%, p=0.43).
HIV-related hyperactivation of mucosal B cells was observed despite early ART initiation. However, early ART appears to limit the loss of BMem compared to CHI as well as prevent increased IgA production by PB. These results provide further insights on mucosal B cell dynamics in HIV infection and another potential mechanism how early ART may limit immune system damage at the mucosal barrier.